Three decades after its introduction as an adjuvant therapeutic option in the management of
selective drug-resistant epilepsy cases (DRE), vagus nerve stimulation (VNS) retains …

Brain diseases, including neurodegenerative, cerebrovascular and neuropsychiatric
diseases, have posed a deleterious threat to human health and brought a great burden to …

Apart from seizure freedom, the presence of comorbidities related to neurological,
cardiovascular, or psychiatric disorders is the largest determinant of a reduced health …

Vagus nerve stimulation (VNS) is an established therapy for drug‐resistant epilepsy.
However, there is a lack of reliable predictors of VNS response in clinical use. The …

Objective: Vagus nerve stimulation (VNS) has been used for adjunctive treatment in drug
resistant epilepsy (DRE) for decades. Nevertheless, information is lacking on possible …

Background Common titration strategies for vagus nerve stimulation (VNS) prioritize
monitoring of tolerability during small increases in stimulation intensity over several months …

Background: Vagus nerve stimulation (VNS) is a palliative treatment for medical intractable
epileptic syndromes not eligible for resective surgery. Health technology assessment (HTA) …

Background: Vagus nerve stimulation (VNS) is a therapeutic approach for patients with
refractory postencephalitic epilepsy (PEE), which is characterized by drug resistance and …

Background Vagus nerve stimulation (VNS) is an effective treatment for patients with
refractory epilepsy, yet with varied predictive factors and heterogeneous long-term …

Objective Vagus nerve stimulation (VNS) Therapy is routinely indicated for people with drug‐
resistant epilepsy (DRE). We analyzed the baseline characteristics of individuals receiving …